AlphAIalphai — Financial news for AI agents
yahoo.comAUG 193 min read$DCGO

DocGo Q2 Earnings Call Highlights

DocGo reported record service volumes in Q2, with year-over-year growth across all core businesses. The company acquired Hicuity, assuming $52M in debt and issuing 2% equity. DocGo's revenue rose to $52M in medical transportation but fell in mobile health due to migrant-related work decline. Adjusted EBITDA loss narrowed to $6.3M. The company updated its full-year outlook, expecting a wider EBITDA loss of $17M-$22M. DocGo has $48.1M in cash and expects positive adjusted EBITDA run rate by year-e

Original reporting
yahoo.com
Published Aug 19, 2026, 9:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 9:48 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
DocGo Q2 Earnings Call Highlights — source image
Source · yahoo.com
Decision brief

The 30-second read

$DCGOBearishMed
01

Why it matters

Earnings miss and widened loss guidance likely trigger sell pressure; acquisition may be a catalyst for future growth.

02

Market read

The report provides fresh earnings numbers, revised guidance, and a strategic acquisition, all of which are new material for traders.

03

What to watch

Potential upside from AI efficiency gains and upcoming Hicuity integration benefits not fully priced yet.

Relevance 7/10Novelty 8/10Timing: post‑market release

Background

DocGo (NASDAQ:DCGO) is a U.S. integrated healthcare provider focusing on mobile clinics and virtual care.

Company-level read

Ticker impact

$DCGOBearishMedium confidence
Context

DocGo reported Q2 results with record service volumes, narrowed full-year revenue outlook to $305M-$310M, widened adjusted EBITDA loss guidance, and announced acquisition of Hicuity with $52M debt assumption and up to $50M financing.

Expected impact

Potential short‑term downside of 5‑10% with volatility, followed by possible recovery if integration outlook improves.

Evidence & confidence

Guidance downgrade and higher loss guidance are immediate negative drivers; the acquisition adds strategic value but is longer‑term.

Market effects

Sector

Highlights growth in on‑demand healthcare services and potential consolidation in mobile health sector.

Regional

US healthcare services segment may see modest re‑rating.

Global

Limited to US small‑cap healthcare investors.

Counterpoint

What could challenge this read

The acquisition could unlock significant synergies, making the stock a buy on long‑term fundamentals despite short‑term earnings miss.

Key entities

  • Company
    DocGo, Inc.

    Subject of earnings release and acquisition announcement.

  • Company
    Hicuity

    Target of acquisition by DocGo.

Read at source← All news

Also covered by

1 outlet

Related articles

AUG 20
Med

DocGo Inc. Q2 2026 Earnings Call Summary

DocGo Inc. reported Q2 2026 earnings, highlighting a 19% year-over-year revenue increase in core business lines, despite a $6.3M adjusted EBITDA loss. The company announced its largest acquisition, Hicuity Health, aiming to integrate hospital and home care. Management expects to achieve positive adjusted EBITDA by year-end 2026, with revenue guidance narrowed to $305M-$310M. Cost synergies and efficiency programs are expected to drive future growth.

yahoo.com2 min
AUG 19
$DCGOMed

DocGo Shares Tumble After Earnings Miss and Wider Loss Forecast

DocGo (DCGO) shares fell 12.7% pre-market Tuesday after Q2 2026 earnings missed estimates, with a $0.16 loss per share vs. expected $0.10. Revenue was $73.4M, down 8.7% YoY, and the company widened its full-year adjusted EBITDA loss forecast to $17M-$22M. The decline followed the end of migrant-related contracts, though core revenue grew 19%. The stock trades near its 52-week low of $0.451.

yahoo.com2 min
AUG 19
$DCGOMed

DocGo Inc (DCGO) (Q2 2026) Earnings Call Highlights: Record Volumes and Strategic

DocGo Inc (DCGO) reported Q2 2026 revenue of $73.4M, down from $80.4M YoY, and widened its adjusted EBITDA loss guidance to $17M-$22M. Gross margins declined due to lower margins in the Mobile Health segment and higher fuel costs. The company's cash position decreased to $48.1M. The Hicuity acquisition faces regulatory and customer approval hurdles. Organic revenue grew approximately 5% YoY. The company aims to achieve adjusted EBITDA breakeven by the end of 2026 through revenue growth, improved

yahoo.com7 min
AUG 18
$DCGOHighAI 9/10

Why is DocGo stock tumbling today?

DocGo (DCGO) shares fell 12.7% pre-open to $0.62 after its Q2 2026 adjusted loss was $0.16 per share versus $0.10 consensus. Revenue was $73.4M, below $75.4M forecast and down 8.7% YoY, tied to wind-down of migrant contracts. It widened FY2026 adjusted EBITDA loss to $17M-$22M and agreed to acquire Hicuity Health (~$65M trailing revenue).

investing.com4 min
AUG 18
$DCGOHighAI 9/10

Why is DocGo stock sliding today?

DocGo (DCGO) shares fell about 12.7% pre-open to $0.62 after its Q2 2026 results missed expectations. Adjusted loss per share was $0.16 vs $0.10 forecast, revenue was $73.4M vs $75.4M. DocGo cut full-year 2026 adjusted EBITDA guidance to a $17M to $22M loss and agreed to acquire Hicuity Health, largely via debt assumption and new financing.

investing.com4 min
AUG 17
$DCGOMed

Why is DocGo stock gaining in after-hours trading today?

DocGo (DCGO) shares rose 2.4% in after-hours to $0.727 after its Q2 2026 earnings release and a 5:00 p.m. ET management call. Analysts expected a 15-cent per-share loss versus a 21-cent loss a year earlier. DocGo also sought a short SEC 10-Q filing extension and reiterated no major operating changes, with prior FY2026 sales guidance raised and a $26M buyback extended.

investing.com5 min